Two symposia at the APA Annual Meeting today are central to the future course of mental health care and psychiatric medicine. In the morning, a panel of researchers from the U.S. and U.K. that have been leaders in effectiveness research will participate in a session on (PS02) Comparative Effectiveness of Psychotropic Drugs: What Can We Learn From Practical Clinical Trials? in which they will present the latest results of comparative effectiveness studies in various disease areas including schizophrenia, bipolar disorder and depression in adult and pediatric populations. These studies reflect the growing need for data on the relative effectiveness of marketed treatments.
The second symposium, (S43) Early Detection and Intervention in Schizophrenia: An Idea Whose Time Has Come, will focus on the strategy of early detection and intervention in psychotic disorders. This model of intervention and service delivery promises to revolutionize the treatment of psychotic disorders and lead to higher rates of recovery and better treatment outcomes. An international group of investigators will present their latest findings which are paving the way for this new intervention strategy.
Jeffrey A. Lieberman, M.D.
Chairman, Department of Psychiatry,
College of Physicians and Surgeons, Columbia University Director, New York State